John Sylvester

John Sylvester has a long and varied work experience, beginning in 1985 with Imerys as Managing Director. In 2000, they moved to Baxter International Inc. as VP Marketing. In 2004, they became Managing Director of Biocompatibles. In 2011, they joined BTG plc as Chief Commercial Officer. In 2013, they were appointed as Non Executive Director of Venture Life Group plc. In 2019, they became an Independent Director of Delcath Systems, Inc. and in 2020 they were appointed Chief Executive Officer - SPECT Intl of Curium Pharma.

John Sylvester attended The University of Manchester from 1983 to 1986, where they obtained a degree in Biochemistry and Applied Molecular Biology. Prior to that, they attended Marple Hall.